La Jolla Pharmaceutical Company
LJPC
LJPC was delisted on the 19th of August, 2022.
80 hedge funds and large institutions have $434M invested in La Jolla Pharmaceutical Company in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 9 closing their positions.
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
68% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 22
50% more call options, than puts
Call options by funds: $996K | Put options by funds: $664K
11% more funds holding
Funds holding: 72 → 80 (+8)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
3% less capital invested
Capital invested by funds: $447M → $434M (-$12.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$7.89M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.82M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$1.98M |
| 4 |
BC
Broadfin Capital
New York
|
+$1.91M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$10.9M |
| 2 |
Morgan Stanley
New York
|
-$3.77M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$1.87M |
| 4 |
DM
Deerfield Management
New York
|
-$1.81M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$1.32M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Barclays
London,
United Kingdom
| $4K | -$263K | -9,654 | -98% |
|
|
IA
77
IFP Advisors
Tampa,
Florida
| $4K | +$4.09K | +150 | New |
|
|
WA
78
WFG Advisors
Dallas,
Texas
| $3K | – | – | – |
|
79
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $1K | +$845 | +31 | New |
|
80
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $212 | +$12K | +440 | +6% |
|
|
DM
81
Deerfield Management
New York
| – | -$1.81M | -65,000 | Closed |
|
|
LOAMU
82
Lombard Odier Asset Management (USA)
New York
| – | -$1.32M | -47,684 | Closed |
|
83
Ameriprise
Minneapolis,
Minnesota
| – | -$1.22M | -43,873 | Closed |
|
84
Renaissance Technologies
New York
| – | -$692K | -24,898 | Closed |
|
85
D.E. Shaw & Co
New York
| – | -$252K | -9,072 | Closed |
|
|
HCM
86
Highbridge Capital Management
New York
| – | -$251K | -9,011 | Closed |
|
87
SEI Investments
Oaks,
Pennsylvania
| – | -$233K | -8,369 | Closed |
|
|
QT
88
Quantbot Technologies
New York
| – | -$66K | -2,391 | Closed |
|
89
Acadian Asset Management
Boston,
Massachusetts
| – | -$18K | -639 | Closed |
|
LJPC Hedge Fund Activity: Q4 2015 in Review
80 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q4 2015, worth a combined $434M — down 2.8% from $447M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new LJPC positions and 9 closed out — a net gain of 8 holders — while 37 added to existing stakes and 22 trimmed.
The largest buyer was State Street, adding an estimated $7.89M. The largest seller was Baker Bros. Advisors, cutting an estimated $10.9M.
- 80 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q4 2015, up from 72 in Q3 2015.
- Funds reported $434M of La Jolla Pharmaceutical Company stock for Q4 2015, down 2.8% quarter-over-quarter.
- 17 funds opened new La Jolla Pharmaceutical Company positions in Q4 2015 and 9 closed out, a net change of +8 holders.
- The largest La Jolla Pharmaceutical Company buyer in Q4 2015 was State Street, an estimated $7.89M added.
- The largest La Jolla Pharmaceutical Company seller in Q4 2015 was Baker Bros. Advisors, an estimated $10.9M sold.
Based on aggregated 13F filings for Q4 2015.